By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Valeant Pharmaceuticals International 

Worldwide Headquarters
One Enterprise
Aliso Viejo  California  92656  U.S.A.
Phone: 800-548-5100 or 949-461-6000 Fax: 714-556-0131


SEARCH JOBS

Valeant Pharmaceuticals International is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. More information about Valeant can be found at www.valeant.com.

YEAR FOUNDED:

1960

LEADERSHIP:

CEO: Joseph C. Papa

CMO: Tage Ramakrishna

CFO: Robert Rosiello

CLINICAL TRIAL:

Please click here for clinical trial information.

JOB OPPORTUNITY:

Please click here for Valeant job opportunities.


Key Statistics


Email:
Ownership: Public

Web Site: Valeant
Employees: 12784
Symbol: VRX
 



Industry
Pharmaceutical


Collaborations

Metabasis Therapeutics, Inc.  – Hepatitis B





Company News
Why Valeant (VRX) CEO Thinks Johnson & Johnson (JNJ) Should Foot The Bill For Their Talc Defense 5/25/2017 6:41:04 AM
EyeGate Pharma Receives Milestone Payment From Valeant (VRX) For EGP-437 For Post-Operative Ocular Inflammation And Pain In Ocular Surgery Patients 5/22/2017 6:35:04 AM
Valeant (VRX) Release: Statement Regarding Xifaxan Intellectual Property Litigation 5/17/2017 9:12:00 AM
Short Seller Who Unraveled Valeant (VRX) Zeroes in On This Massachusetts Biotech 5/16/2017 6:28:57 AM
Is This The Real Reason Valeant (VRX)'s Shares Are Skyrocketing? 5/12/2017 6:15:29 AM
Valeant (VRX) Announces First Quarter 2017 Results And Raises Full Year Adjusted EBITDA Guidance Range 5/9/2017 11:03:17 AM
Valeant (VRX) Announces Key Appointments In Dermatology And Corporate Communications Leadership 5/8/2017 8:28:34 AM
Valeant (VRX) Management Tells The Future, If You Care To Listen 5/5/2017 6:40:14 AM
Embattled Valeant (VRX) Mulls Over Name Change For A Fresh Start 5/3/2017 6:00:27 AM
Valeant (VRX) Announces Additional Debt Reduction Of Approximately $220 Million 5/1/2017 7:31:43 AM
12345678910...
//-->